Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

FDA

When Matthew Feshbach, then an investor, first heard about a California company developing treatments for a variety of diseases using stem cells derived from a patient’s own fat cells (autologous adipose-derived cells), he thought, That’s the biggest idea I’ve ever heard.

Read More